SEARCH HEALTH CONDITIONS BY ALPHABETS

Familial Hibernian Fever



Medications for Tumor Necrosis Factor Receptor Associated Periodic Syndrome

Other names: Familial Hibernian Fever; TNF Receptor Associated Periodic Syndrome; TRAPS

About Tumor Necrosis Factor Receptor Associated Periodic Syndrome:  Tumor necrosis factor receptor associated periodic syndrome (TRAPS) is an inheritable autosomal dominant disorder that is characterized by episodes of fevers. The frequency and length of these episodes varies among individuals. As well as Stress associated symptoms are painful conjunctivitis, rash, and nausea, headache, abdominal pain, and joint pain. Patients who develop amyloidosis of the kidney have a worse prognosis compared to other people. TRAPS ISIS caused by a mutation in the TNFRSF1A gene which results in the protein tumor necrosis factor receptor 1 (TNFR1) being faulty) TNFR1 it has a role in signalling and activating apoptosis and inflammation and is cells, yet in TRAPS the faulty TNFR1 is trapped inside the cells and constantly activates inflammation pathways which leads to excessive inflammation.

Drugs Used to Treat Tumor Necrosis Factor Receptor Associated Periodic Syndrome

This set of medications have been utilized in the treating this particular condition, or in some way related to.

Drug name Rx / OTC Pregnancy CSA AlcoholReviewsRatingPopularity
canakinumabRx C N Insert  inspection
0.0

Generic name: canakinumab systemic

Brand name:  Ilaris

Drug class: interleukin inhibitors

For customers: dose, interactions,

For specialists: Az Drug Facts, AHFS DI Monograph

IlarisRx C N Insert  inspection
0.0

Generic name: canakinumab systemic

Drug class: interleukin inhibitors

For customers: dose, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

Legend

Rxprescription-only
OTCOver the Counter
Rx/OTCPrescription or Over The Counter
Off LabelThis medication might not be accepted by the FDA for the treatment of this particular condition.
Pregnancy Category
Asufficient and well-controlled studies have failed to demonstrate a risk to the embryo in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
BAnimal reproduction studies have failed to show a risk to the fetus and there are no sufficient and well-controlled studies in pregnant women.
CAnimal reproduction studies have shown a negative effect on the fetus and there are no sufficient and well-controlled studies in humans, but possible benefits may warrant used in pregnant women despite potential risks.
DThere is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but possible benefits may warrant used in pregnant women despite potential risks.
XStudies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in used in pregnant women clearly outweigh potential benefits.
NFDA have not classified this drug.
Controlled Substances Act (CSA) Program
Nisn`t at the mercy of the Controlled Substances Act.
1features a higher potential for misuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
Two features a higher potential for misuse. Includes a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Psychotherapy can cause severe physical or psychological dependence.
3features a potential for abuse less than individuals in schedules 1 and 2 two. Includes a currently accepted medical use in treatment in the United States. Psychotherapy can lead to moderate or low physical dependence or high psychological dependence.
4features a very low potential for abuse in accordance with individuals in schedule 3. It`s a currently accepted medical use in treatment in the United States. Psychotherapy can lead to limited physical dependence or psychological dependence.
5features a very low potential for abuse in accordance with individuals in schedule 4. Includes a currently accepted medical use in treatment in the United States. Psychotherapy can lead to limited physical dependence or psychological dependence relative to individuals in schedule 4.
Infection
XInteracts with Medication.

Browse Treatment Plans

  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • that I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • Dtc
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

Further advice

Always ask your healthcare provider to be sure the information displayed on this page pertains to your circumstances.



Top USA Pharma Companies